Healixia is the Belgian community of all professionals active along the life cycle of medicines, medical devices, in vitro diagnostics & other health related products. Members are active in research & development (including pre-clinical, early clinical and later phases), medical affairs, safety, regulatory affairs and market access in industry, academia, investigator sites, authorities, regulatory bodies or in consultancy.

Become a member

Healixia events

  1. medical.png
    25 September '20

    Lunchmeeting: The Anticancer Fund – starts where others stop



    • Dr. Guy Buyens, Medical Director
    • Dr. Gabry Kuijten, Coordinating Physician, My Cancer Navigator
  2. classroom_web.jpg
    28 September '20

    Introduction to Regulatory Affairs 2020


    The course is addressed to people new to regulatory affairs who want to acquire a comprehensive foundation; to regulatory professionals wishing to update their knowledge, and to all collaborators working in close relationship with regulatory affairs and wishing to understand the role of the department.

    The program proposes an introduction to the legal, scientific, organisational and administrative aspects of medical products given by experienced tutors from university, FAMHP and industry.

  3. classroom_web.jpg
    29 September '20

    Session Pharmacovigilance


    More information will follow soon.

Show all meetings


  1. June 2, 2020

    EMA warns against use of unproven cell therapies

    Heard from FAMHP

    The Committee for Advanced Therapies (CAT) of the European Medicines Agency (EMA) advises patients and citizens not to use unregulated cell therapies, which may be unsafe or ineffective.

    Read more

  2. June 2, 2020

    Coronavirus: reminder of the risks of chloroquine and hydroxychloroquine

    Heard from FAMHP

    The FAMHP restates the risks linked to the use of chloroquine and hydroxychloroquine to treat COVID-19 following the publication of a retrospective analysis of a patient monitoring register in the medical journal The Lancet on 22 May 2020. The analysis did not highlight any benefits from these drugs in patients with COVID-19 and revealed adverse cardiovascular effects.

    Read more

  3. June 2, 2020

    Coronavirus: updated guidelines for verifying the compliance and suitability of surgical face masks

    Heard from FAMHP

    The FAMHP has issued guidelines for checking the compliance and suitability of surgical face masks during the COVID-19 crisis. The guidelines are intended for companies, institutions and authorities that order, sell or use these masks.

    Read more

We thank our partners for their support. Click on the logos for more information:
jsn_logo_jj_vert_color_rgb.jpgdigidyco_clinical esolutions_gr_web2.png  keyrus_life_science_logo_HD-WEB.png   Modis 440x320 nieuwsbrief.jpg logo Hebias web.png